Acute arsenic poisoning in two siblings

Pediatrics

Volumn 116, Issue 1, 2005, Pages 249-257

  Lai, Melisa W ^a,b,d,e   Boyer, Edward W ^a,b,c   Kleinman, Monica E ^a,b   Rodig, Nancy M ^a,b   Ewald, Michele Burns ^a,b,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d MOUNT AUBURN HOSPITAL   (United States)

^e American Association of Poison Control Centers   (United States)

Author keywords

Arsenic; British anti lewisite; Chelation therapy; Dimercaprol; DMPS; DMSA; ECMO; Exchange transfusion; Extracorporeal membrane oxygenation; Heavy metal poisoning; Hemodialysis; Pediatric lethal dose; Pharmacokinetics; Poisoning; Succimer; Survival; Toxicokinetics

Indexed keywords

DIMERCAPROL; PESTICIDE; UNITHIOL; HERBICIDE;

ARSENIC POISONING; ARTICLE; CASE REPORT; CHELATION THERAPY; CLINICAL FEATURE; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; INFANT; MALE; NEUROLOGIC EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SIBLING; URINALYSIS; ACUTE DISEASE; FAMILY HEALTH; FATALITY;

ACUTE DISEASE; ARSENIC POISONING; CHILD, PRESCHOOL; FAMILY HEALTH; FATAL OUTCOME; FEMALE; HERBICIDES; HUMANS; INFANT; MALE;

EID: 33644616407     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1957     Document Type: Article

References (48)

1. Wester RC, Hui X, Barbadillo S, et al. In vivo percutaneous absorption of arsenic from water and CCA-treated wood residue. Toxicol Sci. 2004;79:287-295
2. Hemond HF, Solo-Gabriele HM. Children's exposure to arsenic from CCA-treated wooden decks and playground structures. Risk Anal. 2004;24:51-64
3. Stephanopoulos DE, Willman DA, Shevlin D, Pinter L, Gummin DD. Treatment and toxicokinetics of acute pediatric arsenic ingestion: danger of arsenic insecticides in children. Pediatr Crit Care Med. 2002;3:74-80
4. 3) in the treatment of acute promyelocytic leukemia (APL), II: clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997;89:3354-3360
5. Mealey J Jr, Brownell GL, Sweet WH. Radioarsenic in plasma, urine, normal tissues, and intracranial neoplasms: distribution and turnover after intravenous injection in man. AMA Arch Neurol Psychiatry. 1959;81:310-320
6. Delnomdedieu M, Styblo M, Thomas DJ. Time dependence of accumulation and binding of inorganic and organic arsenic species in rabbit erythrocytes. Chem Biol Interact. 1995;98:69-83
7. Pomroy C, Charbonneau SM, McCullough RS, Tam GK. Human retention studies with 74As. Toxicol Appl Pharmacol. 1980;53:550-556
8. Unnikrishnan D, Dutcher JP, Varshneya N, et al. Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood. 2001;97:1514-1516
9. Chiang CE, Luk HN, Wang TM, Ding PY. Prolongation of cardiac repolarization by arsenic trioxide. Blood. 2002;100:2249-2252
10. Novick SC, Warrell RP Jr. Arsenicals in hematologic cancers. Semin Oncol. 2000;27:495-501
11. Ohnishi K, Yoshida H, Shigeno K, et al. Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia. 2002;16:617-622
12. Little RE, Kay GN, Cavender JB, Epstein AE, Plumb VJ. Torsade de pointes and T-U wave alternans associated with arsenic poisoning. Pacing Clin Electrophysiol. 1990;13:164-170
13. Gousios AG, Adelson L. Electrocardiographic and radiographic findings in acute arsenic poisoning. Am J Med. 1959;27:659-663
14. Jolliffe DM, Budd AJ, Gwilt DJ. Massive acute arsenic poisoning. Anaesthesia. 1991;46:288-290
15. Danan M, Dally S, Conso F. Arsenic-induced encephalopathy. Neurology. 1984;34:1524
16. Schoolmeester WL, White DR. Arsenic poisoning. South Med J. 1980;73:198-208
17. Barbey JT, Pezzullo JC, Soignet SL. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J Clin Oncol. 2003;21:3609-3615
18. Abernathy CO, Ohanian EV. Non-carcinogenic effects of inorganic arsenic. Environ Geochem Health. 1992;14:35-41
19. Kamijo Y, Soma K, Asari Y, Ohwada T. Survival after massive arsenic poisoning self-treated by high fluid intake. J Toxicol Clin Toxicol. 1998;36:27-29
20. Campbell JP, Alvarez JA. Acute arsenic intoxication. Am Fam Physician. 1989;40:93-97
21. Fesmire FM, Schauben JL, Roberge RJ. Survival following massive arsenic ingestion. Am J Emerg Med. 1988;6:602-606
22. Watson WA, Veltri JC, Metcalf TJ. Acute arsenic exposure treated with oral d-penicillamine. Vet Hum Toxicol. 1981;23:164-166
23. Kruszewska S, Wiese M, Kolacinski Z, Mielczarska J. The use of haemodialysis and 2,3-propanesulphonate (DMPS) to manage acute oral poisoning by lethal dose of arsenic trioxide. Int J Occup Med Environ Health. 1996;9:111-115
24. Shum S, Whitehead J, Vaughn L, Hale T. Chelation of organoarsenate with dimercaptosuccinic acid. Vet Hum Toxicol. 1995;37:239-242
25. Saady JJ, Blanke RV, Poklis A. Estimation of the body burden of arsenic in a child fatally poisoned by arsenite weedkiller. J Anal Toxicol. 1989;13:310-312
26. Muckter H, Liebl B, Reichl FX, Hunder G, Walther U, Fichtl B. Are we ready to replace dimercaprol (BAL) as an arsenic antidote? Hum Exp Toxicol. 1997;16:460-465
27. Snider TH, Wientjes MG, Joiner RL, Fisher GL. Arsenic distribution in rabbits after lewisite administration and treatment with British antilewisite (BAL). Fundam Appl Toxicol. 1990;14:262-272
28. Habal R. Lead toxicity. Available at: www.emedicine.com/MED/topic1269. htm. Accessed May 18, 2005
29. Miller AL. Dimercaptosuccinic acid (DMSA), a non-toxic, water-soluble treatment for heavy metal toxicity. Altern Med Rev. 1998;3:199-207
30. Schafer B, Kreppel H, Reichl FX, Fichtl B, Forth W. Effect of oral treatment with BAL, DMPS or DMSA arsenic in organs of mice injected with arsenic trioxide. Arch Toxicol Suppl. 1991;14:228-230
31. Heinrich-Ramm R, Schaller H, Horn J, Angerer J. Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning. Arch Toxicol. 2003;77:63-68
32. Aposhian HV, Arroyo A, Cebrian ME, et al. DMPS-arsenic challenge test, I: increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. J Pharmacol Exp Ther. 1997;282:192-200
33. Tomassoni A, Simone K. Case presentation: Church poisonings. In: New England Regional Toxicology Consultants' Conference; Portland, ME: July 26, 2003
34. Styblo M, Drobna Z, Jaspers I, Lin S, Thomas DJ. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect. 2002;110(suppl 5):767-771
35. Gong Z, Jiang G, Cullen WR, Aposhian HV, Le XC. Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate. Chem Res Toxicol. 2002;15:1318-1323
36. Kreppel H, Reichl FX, Forth W, Fichtl B. Lack of effectiveness of d-penicillamine in experimental arsenic poisoning. Vet Hum Toxicol. 1989;31:1-5
37. Martin DS, Willis SE, Cline DM. N-Acetylcysteine in the treatment of human arsenic poisoning. J Am Board Fam Pract. 1990;3:293-296
38. Michaux I, Haufroid V, Dive A, et al. Repetitive endoscopy and continuous alkaline gastric irrigation in a case of arsenic poisoning. J Toxicol Clin Toxicol. 2000;38:471-476
39. Mathieu D, Mathieu-Nolf M, Germain-Alonso M, Neviere R, Furon D, Wattel F. Massive arsenic poisoning: effect of hemodialysis and dimercaprol on arsenic kinetics. Intensive Care Med. 1992;18:47-50
40. Vaziri ND, Upham T, Barton CH. Hemodialysis clearance of arsenic. Clin Toxicol. 1980;17:451-456
41. Chowdhury UK, Rahman MM, Sengupta MK, et al. Pattern of excretion of arsenic compounds [arsenite, arsenate, MMA(V), DMA(V)] in urine of children compared to adults from an arsenic exposed area in Bangladesh. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2003;38:87-113
42. Cullen NM, Wolf LR, St Clair D. Pediatric arsenic ingestion. Am J Emerg Med. 1995;13:432-435
43. Hantson P, Haufroid V, Buchet JP, Mahieu P. Acute arsenic poisoning treated by intravenous dimercaptosuccinic acid (DMSA) and combined extrarenal epuration techniques. J Toxicol Clin Toxicol. 2003;41:1-6
44. Levin-Scherz JK, Patrick JD, Weber FH, Garabedian C Jr. Acute arsenic ingestion. Ann Emerg Med. 1987;16:702-704
45. Smith SB, Wombolt DG, Venkatesan R. Results of hemodialysis and hemoperfusion in the treatment of acute arsenic ingestion. Clin Exp Dial Apheresis. 1981;5:399-404
46. Westervelt P, Pollock JL, Oldfather KM, et al. Adaptive immunity cooperates with liposomal all-trans-retinoic acid (ATRA) to facilitate long-term molecular remissions in mice with acute promyelocytic leukemia. Proc Natl Acad Sci USA. 2002;99:9468-9473
47. Lam MS, Ignoffo RJ. Arsenic trioxide for the treatment of acute promyelocytic leukemia. Cancer Pract. 2001;9:155-157
48. Pai P, Thomas S, Hoenich N, Roberts R, House I, Brown A. Treatment of a case of severe mercuric salt overdose with DMPS (dimercapo-1-propane sulphonate) and continuous haemofiltration. Nephrol Dial Transplant. 2000;15:1889-1890